Inhibition of Protein Phosphatase 2A: Focus on the Glutamatergic System

Molecular Neurobiology

Volumn 53, Issue 6, 2016, Pages 3753-3755

  Zimmer, Eduardo R ^a   Leuzy, Antoine ^b   Souza, Diogo O ^a   Portela, Luis V ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Excitotoxicity; Glutamate; Okadaic acid; Protein phosphatase 2A; Tau hyperphosphorylation

Indexed keywords

CYCLIN DEPENDENT KINASE 5; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE 2A; ENZYME INHIBITOR; PHOSPHOPROTEIN PHOSPHATASE 2;

BINDING AFFINITY; ENZYME ACTIVITY; ENZYME INHIBITION; EXCITOTOXICITY; HUMAN; MOLECULAR DYNAMICS; NEUROTOXICITY; NEUROTRANSMISSION; PATHOPHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOLOGICAL MODEL; METABOLISM;

ANIMALS; ENZYME INHIBITORS; GLUTAMIC ACID; HUMANS; MODELS, BIOLOGICAL; OKADAIC ACID; PROTEIN PHOSPHATASE 2; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84979082782     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-015-9321-0     Document Type: Review

References (14)

1. Gong CX, Singh TJ, Grundke-Iqbal I, Iqbal K (1993) Phosphoprotein phosphatase activities in Alzheimer disease brain. J Neurochem 61(3):921–927
2. Gong CX, Grundke-Iqbal I, Damuni Z, Iqbal K (1994) Dephosphorylation of microtubule-associated protein tau by protein phosphatase-1 and -2C and its implication in Alzheimer disease. FEBS Lett 341(1):94–98
3. Iqbal K, Alonso Adel C, Chen S, Chohan MO, El-Akkad E, Gong CX, Khatoon S, Li B et al (2005) Tau pathology in Alzheimer disease and other tauopathies. Biochim Biophys Acta 1739(2–3):198–210. doi:10.1016/j.bbadis.2004.09.008
4. Zimmer ER, Leuzy A, Bhat V, Gauthier S, Rosa-Neto P (2014) In vivo tracking of tau pathology using positron emission tomography (PET) molecular imaging in small animals. Transl Neurodegen 3(1):6. doi:10.1186/2047-9158-3-6
5. Sontag JM, Sontag E (2014) Protein phosphatase 2A dysfunction in Alzheimer’s disease. Front Mol Neurosci 7:16. doi:10.3389/fnmol.2014.00016
6. Arif M, Kazim SF, Grundke-Iqbal I, Garruto RM, Iqbal K (2014) Tau pathology involves protein phosphatase 2A in parkinsonism-dementia of Guam. Proc Natl Acad Sci U S A 111(3):1144–1149. doi:10.1073/pnas.1322614111
7. Kamat PK, Rai S, Swarnkar S, Shukla R, Nath C (2014) Molecular and cellular mechanism of okadaic acid (OKA)-induced neurotoxicity: a novel tool for Alzheimer’s disease therapeutic application. Mol Neurobiol 50(3):852–865. doi:10.1007/s12035-014-8699-4
8. Cohen P, Klumpp S, Schelling DL (1989) An improved procedure for identifying and quantitating protein phosphatases in mammalian tissues. FEBS Lett 250(2):596–600
9. Gong CX, Lidsky T, Wegiel J, Zuck L, Grundke-Iqbal I, Iqbal K (2000) Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer’s disease. J Biol Chem 275(8):5535–5544
10. Liu F, Grundke-Iqbal I, Iqbal K, Gong CX (2005) Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Euro J Neurosci 22(8):1942–1950. doi:10.1111/j.1460-9568.2005.04391.x
11. Zimmer ER, Kalinine E, Haas CB, Torrez VR, Souza DO, Muller AP, Portela LV (2012) Pretreatment with memantine prevents Alzheimer-like alterations induced by intrahippocampal okadaic acid administration in rats. Curr Alzheimer Res 9(10):1182–1190
12. Kamat PK, Rai S, Swarnkar S, Shukla R, Nath C (2014) Mechanism of synapse redox stress in Okadaic acid (ICV) induced memory impairment: role of NMDA receptor. Neurochem Int 76:32–41. doi:10.1016/j.neuint.2014.06.012
13. Seo J, Giusti-Rodriguez P, Zhou Y, Rudenko A, Cho S, Ota KT, Park C, Patzke H et al (2014) Activity-dependent p25 generation regulates synaptic plasticity and Abeta-induced cognitive impairment. Cell 157(2):486–498. doi:10.1016/j.cell.2014.01.065
14. Robinson DM, Keating GM (2006) Memantine: a review of its use in Alzheimer’s disease. Drugs 66(11):1515–1534